Abstract:Abstract Bacteriophage therapy is a promising approach to address antimicrobial infections though questions remain regarding the impact of the immune response on clinical effectiveness. Here, we develop a mouse model to assess phage treatment using a cocktail of five phages from the Myoviridae and Siphoviridae families that target Vancomycin-Resistant Enterococcus gut colonization. Phage treatment significantly reduces fecal bacterial loads of Vancomycin-Resistant Enterococcus. We also characterize immune responses elicited following administration of the phage cocktail. While minimal innate responses are observed after phage administration, two rounds of treatment induces phage-specific neutralizing antibodies and accelerate phage clearance from tissues. Interestingly, the myophages in our cocktail induce a more robust neutralizing antibody response than the siphophages. This anti-phage immunity reduces the effectiveness of the phage cocktail in our murine model. Collectively, this study shows phage-specific immune responses may be an important consideration in the development of phage cocktails for therapeutic use.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the impact of the host immune response on the efficacy of phage therapy in treating drug - resistant bacterial infections. Specifically, the researchers developed a mouse model to evaluate the therapeutic effect of phage mixtures on vancomycin - resistant enterococcus (VRE) intestinal colonization and explored how phage - specific immune responses affect the long - term effectiveness and reusability of phage therapy. ### Research Background and Objectives Infections caused by antibiotic - resistant bacteria (AMR) have become a major global public health burden, directly causing approximately 1.27 million deaths each year. The spread of drug - resistant strains, especially in medical institutions, has become a serious problem. Among them, vancomycin - resistant enterococcus (VRE) is a typical example. It is not only widely present in hospitals but also one of the main causes of hospital - acquired infections. Phage therapy, as a potential method for treating AMR infections, has the advantages of high specificity and self - dosing behavior by using viruses that target bacteria to treat bacterial infections. However, there are still many unsolved mysteries regarding the impact of the host immune system on phage therapy, especially when this therapy is reused in the same individual. ### Main Research Questions 1. **Efficacy of phage therapy on VRE intestinal colonization**: The researchers developed a mixture containing five phages from the Myoviridae and Siphoviridae families to evaluate their therapeutic effect on VRE intestinal colonization. 2. **Impact of phage - specific immune responses**: The researchers further explored the immune responses triggered by phage therapy, especially the production of phage - specific antibodies and their impact on phage efficacy. ### Research Methods - **Mouse model**: By orally administering VRE to mice and treating them with phage mixtures, the efficacy of phage therapy on VRE intestinal colonization was evaluated. - **Immune response evaluation**: The immune responses, including innate and adaptive immune responses, generated in mice after phage therapy were evaluated by methods such as flow cytometry and ELISA. - **Phage clearance rate**: The phage clearance in vivo was evaluated by detecting the number of phages in mouse feces and tissues. ### Key Findings - **Phage therapy significantly reduces VRE load**: Treatment with phage mixtures significantly reduced the VRE levels in mouse feces. - **Production of phage - specific antibodies**: Phage therapy triggered the production of phage - specific antibodies, especially more intense antibodies against phages of the Myoviridae family. - **Immune responses affect phage efficacy**: The production of phage - specific antibodies accelerated the clearance of phages in tissues, thereby reducing the efficacy of phage therapy, especially when phage therapy was reused. ### Conclusions Phage - specific immune responses, especially the production of phage - specific antibodies, may affect the long - term effectiveness and reusability of phage therapy. This finding is of great significance for designing and optimizing phage mixtures to enhance their clinical application potential.

Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model

Variable fitness effects of bacteriophage resistance mutations in Escherichia coli: implications for phage therapy

Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia

In-vitro resensitization of multidrug resistant clinical isolates of Enterococcus faecium and faecalis through phage-antibiotic synergy

Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci

Repetitive Exposure to Bacteriophage Cocktails against Pseudomonas aeruginosa or Escherichia coli Provokes Marginal Humoral Immunity in Naïve Mice

Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258

Multi-strain phage induced clearance of bacterial infections

In vivo efficacy of phage cocktails against carbapenem resistance Acinetobacter baumannii in the rat pneumonia model

Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of Bacteremia

Evaluation of the impact of repeated intravenous phage doses on mammalian host–phage interactions

The virtue of training: extending phage host spectra against vancomycin-resistant Enterococcus faecium strains using the Appelmans method

Macrophage-induced reduction of bacteriophage density limits the efficacy of in vivo pulmonary phage therapy

Quantitative Models of Phage-Antibiotic Combination Therapy

The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model

Bacteriophage and antibiotic combination therapy for recurrent Enterococcus faecium bacteremia

Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis

Efficacy of φkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection

Phage-phage competition and biofilms reduce the efficacy of a combination of two virulent bacteriophages against

Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy

Phage therapy combats pandrug-resistant Acinetobacter baumannii infection safely and efficiently